Trifolirhizin inhibits proliferation, migration and invasion in nasopharyngeal carcinoma cells via PI3K/Akt signaling pathway suppression

被引:10
|
作者
Jiang, Xing [1 ]
Yin, Haihui [2 ]
Su, Wenqing [3 ]
Quan, Haiyan [4 ]
Yuan, Xinye [1 ]
Feng, Xu [1 ]
Li, Pei [1 ]
He, Yan [1 ]
Xiao, Junhui [1 ]
Li, Rong [1 ]
机构
[1] Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Dept Pharm, Hengyang 421001, Hunan, Peoples R China
[2] Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Dept Med Ultrasound, Hengyang 421001, Hunan, Peoples R China
[3] Youjiang Med Univ Nationalities, Baise 533000, Guangxi, Peoples R China
[4] Hunan Polytech Environm & Biol, Hengyang 421001, Hunan, Peoples R China
关键词
Nasopharyngeal carcinoma; Proliferation; Migration; Invasion; Signaling pathway; SOPHORA-FLAVESCENS; MEDICINE; CANCER;
D O I
10.1016/j.bbrc.2023.05.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nasopharyngeal carcinoma (NPC) is a highly recurrent and metastatic malignant tumor affecting a large number of individuals in southern China. Traditional Chinese herbal medicine has been found to be a rich source of natural compounds with mild therapeutic effects and minimal side effects, making them increasingly popular for treating various diseases. Trifolirhizin, a natural flavonoid derived from legu-minous plants, has gained significant attention for its therapeutic potential. In this study, we confirmed that trifolirhizin could effectively inhibit the proliferation, migration and invasion of nasopharyngeal carcinoma 6-10B and HK1 cells. Furthermore, our findings demonstrated that trifolirhizin achieves this by suppressing the PI3K/Akt signaling pathway. The findings of the present study provides a valuable perspective on the potential therapeutic applications of trifolirhizin for the treatment of nasopharyngeal carcinoma.(c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 50 条
  • [21] ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma
    Hu, Qian
    Lin, Xiao
    Ding, Linxiaoxiao
    Zeng, Yinduo
    Pang, Danmei
    Ouyang, Nengtai
    Xiang, Yanqun
    Yao, Herui
    CANCER MEDICINE, 2018, 7 (08): : 3862 - 3874
  • [22] Artesunate inhibits proliferation, migration, and invasion of thyroid cancer cells by regulating the PI3K/AKT/FKHR pathway
    Xu, Zhiwei
    Liu, Xiaojian
    Zhuang, Daoping
    BIOCHEMISTRY AND CELL BIOLOGY, 2022, 100 (01) : 85 - 92
  • [23] Echinacoside inhibits the proliferation, migration, invasion and angiogenesis of ovarian cancer cells through PI3K/AKT pathway
    Juan Liu
    Ni Tang
    Ni Liu
    Panpan Lei
    Fang Wang
    Journal of Molecular Histology, 2022, 53 : 493 - 502
  • [24] Echinacoside inhibits the proliferation, migration, invasion and angiogenesis of ovarian cancer cells through PI3K/AKT pathway
    Liu, Juan
    Tang, Ni
    Liu, Ni
    Lei, Panpan
    Wang, Fang
    JOURNAL OF MOLECULAR HISTOLOGY, 2022, 53 (02) : 493 - 502
  • [25] Tanshinol inhibits the growth, migration and invasion of hepatocellular carcinoma cells via regulating the PI3K-AKT signaling pathway
    Zhu, Pingting
    Liu, Zhaoguo
    Zhou, JiaoJiao
    Chen, Yuanyuan
    ONCOTARGETS AND THERAPY, 2019, 12 : 87 - 99
  • [26] Glutinol inhibits the proliferation of human ovarian cancer cells via PI3K/AKT signaling pathway
    Chen, Yuanyuan
    Lie, Juan
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (07) : 1331 - 1335
  • [27] Isorhamnetin inhibits cholangiocarcinoma proliferation and metastasis via PI3K/AKT signaling pathway
    Tan, Zhiguo
    Liu, Jie
    Hou, Min
    Zhou, Jia
    Chen, Yu
    Chen, Xu
    Leng, Yufang
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [28] LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway
    Bi, Q. -J.
    Men, X. -J.
    Han, R.
    Li, G. -L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (10) : 3067 - 3073
  • [29] Mifepristone inhibits proliferation, migration and invasion of HUUA cells and promotes its apoptosis by regulation of FAK and PI3K/AKT signaling pathway
    Sang, Lin
    Lu, Dawei
    Zhang, Jun
    Du, Shihua
    Zhao, Xingbo
    ONCOTARGETS AND THERAPY, 2018, 11 : 5441 - 5449
  • [30] Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells
    Nowicki, Theodore S.
    Zhao, Hong
    Darzynkiewicz, Zbigniew
    Moscatello, Augustine
    Shin, Edward
    Schantz, Stimson
    Tiwari, Raj K.
    Geliebter, Jan
    CELL CYCLE, 2011, 10 (01) : 100 - 107